David Holland - Alimera Sciences Insider

Alimera Sciences Inc -- USA Stock  

USD 1.09  0.01  0.91%

Co-Founder and Sr. VP of Sales and Marketing

Mr. David R. Holland is the Senior Vice President Sales and Marketing of Alimera Sciences, Inc. Prior cofounders and served as the Vice President of Marketing since the founding of our Company in 2003 through August 2010 when he was appointed the Senior Vice President of Sales and Marketing. Prior to founding our Company, Mr. Holland served as the Vice President of Marketing of Novartis Ophthalmics from 1998 to 2003. In 1997, Mr. Holland served as Global Head of the Lens Business at CIBA Vision and in 1996, Global Head of the Lens Care Business of CIBA Vision. From 1992 to 1995, Mr. Holland served as the Director of Marketing for CIBA Vision Ophthalmics. From 1989 to 1991, Mr. Holland served as New Products Manager for CIBA Vision. From 1985 to 1989, Mr. Holland served as a Brand Assistant and Assistant Brand Manager of Procter and Gamble. Mr. Holland holds an A.B. in Politics from Princeton University.
Age: 51  Founder Since 2010      
678-990-5740  http://www.alimerasciences.com

David Holland Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (15.8) % which means that it has lost $15.8 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (108.63) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 34.75 M in liabilities with Debt to Equity (D/E) ratio of 232.9 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Alimera Sciences Inc has Current Ratio of 3.99 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Entity Summary

Alimera Sciences, Inc., a pharmaceutical company, engages in the research, development, and commercialization of prescription ophthalmic pharmaceuticals in the United States and internationally. Alimera Sciences, Inc. was founded in 2003 and is headquartered in Alpharetta, Georgia. Alimera Sciences operates under Drug Manufacturers - Major classification in USA and traded on NASDAQ General Markets. It employs 118 people.Alimera Sciences Inc (ALIM) is traded on NASDAQ General Markets in USA. It is located in GEORGIA, U.S.A and employs 118 people. Alimera Sciences is listed under Pharmaceutical Products category by Fama And French industry classification.

Did you try this?

Run Money Managers Now

Money Managers

Screen money managers from public funds and ETFs managed around the world
Hide  View All  NextLaunch Money Managers

Fix Portfolio

Optimize Your Risk-Return Tradeoff
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Alimera Sciences Inc to your portfolio

Top Management

Alimera Sciences Inc Leadership Team
David Burke, President
Philip Ashman, Managing Director, Ph.D
David Holland, Founder
James Largent, Director, MBA
Peter Pizzo, Director, Ph.D
Kenneth Green, SVP, Ph.D
Richard Eiswirth, CFO
Brian Halak, Director, Ph.D
Calvin Roberts, Director, Ph.D
Daniel Myers, CEO
Mark Brooks, Director, MBA
Rich Cockrell, President

Stock Performance

Alimera Sciences Performance Indicators